Our previous published research in brain cancer (12) identified the 5hmC modification level of the PRR15 gene (encoding ‘proline rich 15’), specifically its gene body modification as one of the cfDNA-based diagnostic markers for gliomas. This evidence concerns the gene PRR15 and central nervous system cancer.